S
S. P. Stenning
Researcher at University College London
Publications - 68
Citations - 4572
S. P. Stenning is an academic researcher from University College London. The author has contributed to research in topics: Cancer & Epirubicin. The author has an hindex of 24, co-authored 68 publications receiving 4192 citations. Previous affiliations of S. P. Stenning include The Royal Marsden NHS Foundation Trust.
Papers
More filters
Journal Article
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
Graham M. Mead,S. P. Stenning,P. A. Cook,Sophie D. Fosså,Alan Horwich,Stan B. Kaye,R.T.D. Oliver,Phm deMulder,R deWit,Gerrit Stoter,Richard Sylvester,Dean F. Bajorin,George J. Bosl,M Mazumdar,Craig R. Nichols,Robert J. Amato,Giorgio Pizzocaro,Jean-Pierre Droz,Andrew Kramar,Gedske Daugaard,H. Cortes-Funes,Luis Paz-Ares,John A. Levi,B. M. Colls,V J Harvey,C Coppin +25 more
TL;DR: An easily applicable, clinically based, prognostic classification for GCT has been agreed on between all the major clinical trial groups who are presently active worldwide and should be used in clinical practice and in the design and reporting of clinical trials to aid international collaboration and understanding.
Journal ArticleDOI
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.
TL;DR: This study confirms the safety of surveillance after orchidectomy alone in patients with stage I nonseminomatous germ cell testicular tumor and identifies a group of patients with a high risk of relapse.
Journal ArticleDOI
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C Smyth,Andrew Wotherspoon,Clare Peckitt,David Gonzalez,Sanna Hulkki-Wilson,Zakaria Eltahir,Matteo Fassan,Massimo Rugge,Nicola Valeri,Nicola Valeri,Alicia Okines,Madeleine Hewish,William H. Allum,S. P. Stenning,Matthew Nankivell,Ruth E Langley,David Cunningham +16 more
TL;DR: In the MAGIC trial, MMRD and high MSI were associated with a positive prognostic effect in patients treated with surgery alone and a differentially negative prognosticEffect in patients treating with chemotherapy.
Journal ArticleDOI
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study
Graham M. Mead,Matthew R. Sydes,Jan Walewski,Andrew Grigg,C. S. Hatton,P. Norbert,C. Guarnaccia,M. S. Lewis,Joseph McKendrick,S. P. Stenning,D. Wright +10 more
TL;DR: A larger, international, multi-centre study using International Prognostic Index-based criteria to assign prognostic groups, whilst slightly simplifying the protocol confirms high cure rates with this CODOX-M/IVAC approach.
Journal ArticleDOI
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.
Michael Cullen,S. P. Stenning,M. C. Parkinson,Sophie D. Fosså,Stan B. Kaye,Alan Horwich,S. J. Harland,M. V. Williams,R Jakes +8 more
TL;DR: Adjuvant chemotherapy is free from significant long-term toxicity, offering an effective alternative to surveillance or retroperitoneal lymph node dissection followed by surveillance, and may be preferred by some patients.